No current content.
Abdera Therapeutics Inc. is a precision oncology company leveraging antibody engineering to design and develop next-generation targeted radiation therapeutics for cancer - one of the most cutting-edge and highly promising areas of drug development. The company is built on a proprietary modular technology platform optimized for the delivery of radioisotopes to selectively destroy tumor cells while sparing healthy cells. Abdera is using this platform to enable the rapid development of a broad range of safe and efficacious therapies serving cancer patients with limited treatment options.
No current content.